Ting Shan

1.1k total citations
36 papers, 888 citations indexed

About

Ting Shan is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Ting Shan has authored 36 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Biomedical Engineering. Recurrent topics in Ting Shan's work include Cancer-related molecular mechanisms research (6 papers), Nanoplatforms for cancer theranostics (6 papers) and MicroRNA in disease regulation (5 papers). Ting Shan is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Nanoplatforms for cancer theranostics (6 papers) and MicroRNA in disease regulation (5 papers). Ting Shan collaborates with scholars based in China and United States. Ting Shan's co-authors include T. K. Kwei, Eli M. Pearce, Yanjuan Huang, Zeqian Huang, Xiaoyu Xu, Jiazeng Xia, Kaiyuan Deng, Chunshun Zhao, Zishan Zeng and Meixu Chen and has published in prestigious journals such as Molecular Cell, Biomaterials and Cancer.

In The Last Decade

Ting Shan

35 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ting Shan China	18	406	257	190	134	126	36	888
Meng Xiong China	21	639 1.6×	97 0.4×	300 1.6×	155 1.2×	89 0.7×	58	1.2k
Dongsheng He China	22	673 1.7×	95 0.4×	393 2.1×	125 0.9×	117 0.9×	57	1.2k
Qingning Li China	15	397 1.0×	157 0.6×	289 1.5×	294 2.2×	53 0.4×	31	987
Guodong Ye China	13	368 0.9×	153 0.6×	85 0.4×	76 0.6×	66 0.5×	53	713
Kunchi Zhang China	14	387 1.0×	162 0.6×	275 1.4×	155 1.2×	30 0.2×	26	761
Rongliang Tong China	19	734 1.8×	430 1.7×	267 1.4×	181 1.4×	45 0.4×	33	1.3k
Chi Hin Wong Hong Kong	13	423 1.0×	291 1.1×	99 0.5×	77 0.6×	32 0.3×	22	756
Claudia Bellomo Sweden	11	324 0.8×	119 0.5×	211 1.1×	137 1.0×	55 0.4×	15	899
Vinit Kumar India	20	500 1.2×	153 0.6×	229 1.2×	289 2.2×	38 0.3×	42	1.1k
Jae Min Jung South Korea	21	380 0.9×	96 0.4×	147 0.8×	239 1.8×	57 0.5×	34	950

Countries citing papers authored by Ting Shan

Since Specialization

Citations

This map shows the geographic impact of Ting Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Shan more than expected).

Fields of papers citing papers by Ting Shan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Shan. The network helps show where Ting Shan may publish in the future.

Co-authorship network of co-authors of Ting Shan

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Shan. A scholar is included among the top collaborators of Ting Shan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Shan. Ting Shan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Wenxin, Wanqian Li, Bin Xu, et al.. (2025). Plasmodium Infection Modulates Host Inflammatory Response through circRNAs during the Intracellular Stage in Red Blood Cells. ACS Infectious Diseases. 11(4). 1018–1029.

Shan, Ting, Zonggui Chen, Shaopeng Li, et al.. (2023). m6A modification negatively regulates translation by switching mRNA from polysome to P-body via IGF2BP3. Molecular Cell. 83(24). 4494–4508.e6. 26 indexed citations

Zeng, Zishan, Xiaoyu Xu, Ting Shan, et al.. (2023). A mitochondria-targeting ROS-activated nanoprodrug for self-augmented antitumor oxidation therapy. Journal of Controlled Release. 359. 415–427. 31 indexed citations

Zhou, Peng, Xingyu Chen, Ning Wang, et al.. (2023). ATF4-mediated circTDRD3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-891b/ITGA2 axis and AKT signaling pathway. Gastric Cancer. 26(4). 565–579. 9 indexed citations

Luo, Yong, Zishan Zeng, Ting Shan, et al.. (2022). Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy. Theranostics. 12(8). 3610–3627. 23 indexed citations

Zhou, Yunting, Yuming Wang, Huiying Wang, et al.. (2022). Perilipin 2 Protects against Lipotoxicity‐Induced Islet Fibrosis by Inducing Islet Stellate Cell Activation Phenotype Changes. BioMed Research International. 2022(1). 4581405–4581405. 1 indexed citations

Ding, Xin, Xiaoyu Xu, Zishan Zeng, et al.. (2022). Tumor-targeted hyaluronic acid-based oxidative stress nanoamplifier with ROS generation and GSH depletion for antitumor therapy. International Journal of Biological Macromolecules. 207. 771–783. 46 indexed citations

Chen, Jie, Yanjuan Huang, Congjun Xu, et al.. (2022). Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy. Biomaterials. 284. 121513–121513. 43 indexed citations

Xu, Xiaoyu, Zishan Zeng, Xin Ding, et al.. (2021). Reactive oxygen species-activatable self-amplifying Watson-Crick base pairing-inspired supramolecular nanoprodrug for tumor-specific therapy. Biomaterials. 277. 121128–121128. 37 indexed citations

10.

Chen, Ye, et al.. (2020). Inhibition of miR-16 Ameliorates Inflammatory Bowel Disease by Modulating Bcl-2 in Mouse Models. Journal of Surgical Research. 253. 185–192. 11 indexed citations

11.

Wang, Ning, Keyu Lu, Hao Wang, et al.. (2020). CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. Biomedicine & Pharmacotherapy. 125. 109876–109876. 39 indexed citations

12.

Wang, Hao, Yi-Gang Chen, Jian Guo, et al.. (2018). Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1. Scientific Reports. 8(1). 7080–7080. 11 indexed citations

13.

Guo, Xiaoqiang, Li Deng, Kaiyuan Deng, et al.. (2016). Pseudogene PTENP1 Suppresses Gastric Cancer Progression by Modulating PTEN. Anti-Cancer Agents in Medicinal Chemistry. 16(4). 456–464. 39 indexed citations

14.

Deng, Kaiyuan, Ting Shan, Yigang Chen, et al.. (2016). Tristetraprolin inhibits gastric cancer progression through suppression of IL-33. Scientific Reports. 6(1). 24505–24505. 33 indexed citations

15.

Guo, Xiaoqiang, Kaiyuan Deng, Hao Wang, et al.. (2015). GAS5 Inhibits Gastric Cancer Cell Proliferation Partly by Modulating CDK6. Oncology Research and Treatment. 38(7-8). 362–366. 48 indexed citations

16.

Lyu, Yaqing, et al.. (2015). Effect of Alemtuzumab on Intestinal Intraepithelial Lymphocytes and Intestinal Barrier Function in Cynomolgus Model. Chinese Medical Journal. 128(5). 680–686. 7 indexed citations

17.

Xia, Jiazeng, Feng Ju, Yan Jiang, et al.. (2013). MicroRNA-148a Can Regulate Runt-Related Transcription Factor 3 Gene Expression via Modulation of DNA Methyltransferase 1 in Gastric Cancer. Molecules and Cells. 35(4). 313–319. 35 indexed citations

18.

Yu, Chao, Ting Shan, Aiwen Feng, et al.. (2011). Triptolide ameliorates Crohn's colitis is associated with inhibition of TLRs/NF-κB signaling pathway. Fitoterapia. 82(4). 709–715. 34 indexed citations

19.

Shan, Ting, Jingbin Zhang, Qiurong Li, et al.. (2010). Lymphocyte Depletion and Repopulation in Peripheral Blood and Small Intestine of Cynomolgus Monkeys After Alemtuzumab Treatment. Journal of Surgical Research. 167(1). e21–e27. 2 indexed citations

20.

Messerschmidt, Gerald L., Robert Makuch, F R Appelbaum, et al.. (1988). A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients. Cancer. 62(4). 795–801. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact